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on the Nucleated Cell Yields of Bone Marrow Collection
Tso-Fu Wang,1,2 Sung-Chao Chu,1 Shu-Huey Chen,2,3,4 Kuan-Po Huang,1 Yu-Chieh Su,4,5
Dian-Kun Li,4,5 Ming-Hwang Shyr,2,4 Chu-Yu Chang,2 Hsi-Hsiu Tsai,6 Ruey-Ho Kao1,4To improve bone marrow (BM) harvest of the volunteer donors in our institute, we changed from the single-
hole needle to the multi–side-hole needle after March 2002, and examined the midway total nucleated cell
(TNC) counts during collection after September 2004. The aims of this retrospective study were to evaluate
BM harvest yields obtained through different strategies and to examine the correlation between final and mid-
way BM harvests. The distribution of BM harvesting by different strategies was 235 donors with single-hole
needles (group A), 389 donors with 5–side-hole needles (group B), and 365 donors with 5–side-hole needles
and midway TNC counts (group C). The nucleated cell density of the collected BM was significantly improved
by modifying the harvest strategy (0.202 108/mL in group A, 0.219 108/mL in group B, and 0.250 108/mL
in group C; P\.001). The percentage of unacceptable TNC dose (\2  108/kg) was also decreased in all 3
groups (to 5.9%, 3.6%, and 0%, respectively; P \ .001). Multiple regression analysis revealed that donor
weight, white blood cell count, and harvest strategy were positively correlated with BM TNC density
(P\.001), whereas harvested BM volume was negatively correlated with TNC density (P\.001). On linear
regression analysis, highly significant correlations were noted between midway and final TNC densities
(r5 0.8774; P\.001) as well as between harvested BM volume and TNC count (r5 0.7937; P\.001). Changing
the harvesting needle and checking the midway TNC count improved the harvest outcome.
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Over the past several decades, bone marrow trans-
plantation (BMT) has been used to successfully treat
numerous malignant and nonmalignant hematologic
diseases. After HLA matching, adequate BM cell dose
is one of themost important donor factors in successful
hematopoietic stem cell (HSC) transplantation. The
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6/j.bbmt.2010.05.013of nucleated cells per kg of recipient body weight. A
higher total nucleated cell (TNC) count will improve
patient outcomes [1-4]. An unacceptable cell dose
has been recommended as the nucleated cells were
\2 108/kg [5], but it is difficult to predict final harvest
yield before this procedure. We have previously
demonstrated that donor body weight and baseline
white blood cell (WBC) count are positively correlated
with the cell density of the collected BM, whereas
harvested BM volume is negatively correlated with
cell density [6]. None of these donor factors except
BM harvest volume is modifiable, however.
It is important tominimize the side effects of theBM
harvesting procedure on the donor and also to have
a sufficient volume of collected BM to ensure a better
recipient outcome. Few previous studies have addressed
strategies to improve the harvest yield of BM collection.
Most of these focused on the amount of aspiration
at each puncture site or the use of granulocyte colony-
stimulating factor (G-CSF) as priming [7-11]. Less
aspiration per puncture might increase the TNC count
by avoiding contamination of peripheral blood (PB),
but this strategy will increase the number of punctures
and prolong the duration of anesthesia, both of
which are strongly associated with BM harvest
complications [12]. Higher total collected BM volume351
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collection symptoms, such as those of anemia.
The Tzu-Chi Marrow Donor Registry was
established in 1993 and was renamed the Buddhist
Tzu-Chi StemCell Center (BTCSCC) in 2002. There
are currently 330,000 enrolled donors, with .2000
stem cell collections (1136 BM and 940 PB stem cell
[PBSC]) performed as of December 2009. The
BTCSCC is one of the most active HSC registries in
Asia, with .50% of the HSC donations destined for
patients overseas. To improve the BMharvest outcome
in our institute, we changed some of our harvest strat-
egies in recent years. First, we changed from a single-
hole needle to a multi–side-hole needle in March
2002. The harvest needle that we currently use has 5
side holes in addition to the tip hole and can aspirate
6 separate BM compartments simultaneously. Theo-
retically, use of the multi–side-hole needle can reduce
the harvest time and minimize the contamination of
PB. Meanwhile, the shorter operation time and anes-
thesia also might decrease BM harvest complications
for the donors. Second, to avoid unacceptable nucle-
ated cell doses for transplantation, in September
2004, we started to check the TNC count midway
during BM collection in the main harvest center,
Tzu-Chi General Hospital in Hualien. The midway
TNC count might help the attending physician deter-
mine the final harvested BM volume.
The aim of this retrospective study was to evaluate
the effect of the changes in harvest strategies on BM
harvests in our institution. BM nucleated cell density
(TNCs per mL of harvested BM) was used as the major
outcome indicator of harvest yield for comparisons, to
avoid bias resulting from varying recipient weight and
donor harvest volumes. The correlations among TNC
count, harvested BM volume, and TNC density of col-
lected BM also were analyzed to help predict harvest
outcome.MATERIALS AND METHODS
Between January 1999 and July 2009, all healthy
volunteers who underwent BM donation at the
Buddhist Tzu-Chi Stem Cell Center were included in
this retrospective analysis. Standard BM harvest
procedures were performed by staff at the Department
of Oncology and Hematology in the 2 branches of
Tzu-Chi General Hospital (Hualien and Dalin). All
participants agreed to BM stem cell donation after re-
ceiving explanations of the procedures for BM harvest
and PBSC collection. Informed consent was obtained
from each donor before the harvest procedure. The
study design was approved by the hospital’s Institu-
tional Review Board.
Under general anesthesia, BM was aspirated from
the bilateral posterior iliac crest using a single-holeneedle. After March 2002, our institution replaced
the single-hole harvest needle with a new harvest nee-
dle with 5 additional side holes. The targeted final
collected BM volume was estimated by 20 mL per kg
of the recipient’s body weight, with a maximum
amount of 20 mL per kg of the donor’s body weight.
To reduce the contamination of PB in the harvested
BM, the volume of each aspiration was restricted to
5 mL with the single-hole needle and 30 mL with
the multi–side-hole needle. A technician monitored
the amount of aspiration during BM collection. After
September 2004, the midway TNC count was checked
at Tzu-Chi Hospital Hualien by the consensus of
harvest physicians. Two mL of harvested BM was
sent for TNC counting at approximately the midway
point of the targeted harvest volume. The stopping
point of the harvest was at the discretion of the attend-
ing physician, based on collecting 20 mL of BM per kg
of recipient weight and the midway TNC count if data
were available. The collected BM was mixed with
citrate dextrose (ACD) at a ratio of 0.28 and filtered
through 500-mm and 200-mm filters successively.
The total volume of the harvested BM was obtained
by subtracting the volume of anticoagulant from the
volume of the mix. The midway and final nucleated
cell concentrations of the harvested BM were
determined using an automatic hematology analyzer
(XE-2100; Sysmex, Kobe, Japan). The TNC density
in the harvested BM was determined by dividing the
number of TNCs by the volume of the harvested BM.
Statistical Analysis
Analysis of variance and the c2 test were used to
determine the significance of differences between the
different strategy cohorts. The TNC density of har-
vested BM was correlated with donor characteristics,
including age, sex, body weight, and baseline white
blood cell (WBC) count, and harvest strategies by
multiple regression analysis. The cell densities of the
midway and final harvest products were compared us-
ing the paired-sample t test. Linear regression analysis
was used to evaluate the relationship betweenharvested
BMvolume,TNCcount, and cell densities in donors in
whom both midway and final TNC counts were
checked. A P value\ .05 was considered statistically
significant. All analyses were done using MedCalc
for Windows, version 9.6.0.0 (MedCalc Software,
Mariakerke, Belgium).RESULTS
A total of 989 volunteer donors (408 [41.3%]males;
mean age, 29.6 years [range, 17-55 years]) underwent
BM harvest for unrelated BM transplantation at
Tzu-Chi General Hospital in Hualien and Dalin dur-
ing the study period. The distribution of BM harvests
Table 1. Donor Characteristics and Results of BM Harvesting
Group A Group B Group C P
N 235 389 365
M/F, % 38/62 38/62 47/53 .024
Age, years 29.4 29.1 30.3 .055
Donor BW, kg 63.9 64.6 64.2 .779
BM volume, mL 944 (232-1250) 927 (203-1473) 995 (568-1599) <.001
Recipient BW, kg 56.1 52.1 53.9 .045
BM/recipient weight, mL/kg 18.6 20.2 20.7 .005
Baseline WBC count, 103/mL 5.97 5.95 6.25 .020
TNC count, 108 cells 189 (37.2-444) 201 (26.9-475) 245 (93.8-477.5) <.001
Cell density, 108/mL 0.202 (0.088-0.427) 0.219 (0.072-0.462) 0.250 (0.118-0.610) <.001
Cell dose, 108/kg 3.79 (1.33-15.5) 4.46 (0.99-19.2) 5.19 (2.01-27.8) <.001
Cell dose <2  108/kg, % 5.9% 3.6% 0% <.001
Cell dose >5  108/kg, % 15.7% 28.3% 38.6% <.001
BM indicates bone marrow; BW, body weight; TNC, total nucleated cell.
Data are presented as mean unless indicated otherwise. Cell density, TNC/volume  108/mL of BM; cell dose, TNCs/recipient weight  108/kg of
recipient weight.
Table 2. Correlation of Cell Density of BM Harvest and
Donor Characteristics on Multiple Regression Analysis
P
Age .059
Sex .838
Donor weight <.001
WBC count <.001
Harvest strategy <.001
BM volume <.001
BM indicates bone marrow; WBC, white blood cell.
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hole needle (group A), 389 donors with a 5–side-hole
needle (group B), and 365 donors with a 5–side-hole
needle and a midway TNC value (group C). There
were 46 donors at Tzu-Chi Hospital Dalin, all of
whom were in group B. Donor characteristics and
harvest outcomes of the 3 groups are summarized in
Table 1. Mean age and donor body weight did not
differ among the 3 groups. The recipient weight was
significantly greater in group A compared with group
B, but not compared with group C (56.1, 52.1, and
53.9 kg, respectively; P 5 .045). The baseline WBC
count was slightly higher in group C compared with
groups A and B (5.97  103/mL, 5.95  103/mL, and
6.25  103/mL, respectively; P 5 .02). The final
harvested BM volume and the BM volume per kg of
recipient weight were significantly higher in group C
(944 mL, 927 mL, and 995 mL [P \ .001]
and 18.6 mL, 20.2 mL, and 20.7 mL/kg [P 5 0.005],
respectively).
Changing the harvest needle and checking the
midway TNC count were associated with significant
increases in nucleated cell density in the harvested
BM in all 3 groups (0.202  108/mL in group A,
0.219  108/mL in group B, and 0.250  108/mL
in group C; P\ .001). The other outcome parameters,
including final TNC count and cell dose per recipient
weight, were also improved in all 3 groups (189  108,
201 108, and 245 108 [P\ .001] and 3.79 108/kg,
4.46  108/kg, and 5.19  108/kg [P\ .001], respec-
tively). The percentage of unacceptable TNC dose
(\2  108/kg) was decreased (to 5.9%, 3.6%, and
0%, respectively; P\ .001) by modifying the harvest
strategy.
The multiple regression analysis revealed that do-
nor weight, baseline WBC count, harvest group, and
harvest BM volume were statistically significantly
correlated with the nucleated cell density of the har-
vested BM (Table 2). Donor body weight, WBC
count, and harvest group were positively correlatedwith the cell density of the BM harvest (all P values
were \.001), whereas the total volume of the
harvested BM was negatively correlated with the cell
density of the BMharvest (P\.001). There was a trend
of correlation between donor age and cell density
(P 5 .059).
Base on linear regression, a highly significant
correlation was found between the harvested BM
volume and the midway and final TNC counts in
group C (n 5 730; r 5 0.7937; P\ .001; Figure 1).
The regression equation was TNC (y) 5 40.0823 1
0.2057  BM volume (x). The mean cell density of
the final harvested BM was significantly lower than
that of the midway harvested BM (0.250  108/mL
vs 0.292  108/mL; P\ .001). The midway and final
BM cell densities were closely correlated (n 5 365;
r5 0.8774; P\ . 001; Figure 2). The regression equa-
tion was final cell density (y) 5 0.06787 1 0.6234 
midway cell density (x).DISCUSSION
As the number of volunteer HSC donors increases
worldwide, many more patients can have multiple
HLA-matched donors. A recent National Marrow
Donor Program (NMDP) report noted that 56% of
patients have $10 suitably HLA matched donors in
the current NMDP files [13]. We have demonstrated
that donor body weight and baseline WBC cell count
Figure 1. The correlation between TNC count and harvest BM volume
in group C (n 5 730; r 5 0.7937; P\.001). The regression equation is
TNC (y)5 40.08231 0.2057  BM volume (x).
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collected BM, whereas harvest BM volume is nega-
tively correlated with the cell density [6]. These donor
factors can help guide physicians in selecting an opti-
mal donor to provide a sufficient BM cell dose. Once
the donor is chosen, the yield of the collected BM
depends on the harvest procedure.
Two ways of increasing BM harvest outcome in
a chosen donor are to increase the collected volume or
increase the cell densityof theharvestedBM.The target
volume of BM collection has been empirically based on
the weight of the adult recipient, with a target of 15-20
mL of BM per kg recipient weight. Although this
method is widely used, a significant percentage (27%-
50%) of recipients receive a relatively low BM cell
dose (\2.4-2.6  108/kg) [3,4]. To obtain a higher
infused nucleated cell dose for transplantation,
physicians usually tend to collect as high a BM volume
as possible. For donors, this strategy can prolong the
anesthesia time, increase the number of puncture
sites, and increase blood loss. A large BM volume also
might be harmful to the recipient because of the riskFigure 2. The correlation between midway and final BM cell density
(n 5 365; r 5 0.8774; P\ .001). The regression equation is final cell
density (y) 5 0.06787 1 0.6234  midway cell density (x).of fluid overload. The most effective and safe way to
reach the target cell dose is to increase the cell density
in the collected BM. In this study, we analyzed
strategies aimed at improving BM harvest outcomes
by increasing cell density instead of increasing the
collected BM volume.
In contrast to marked advances in BM transplanta-
tion, BM harvest techniques are well established and
have remained unchanged for many years except
for the introduction of new harvest needles with
multiple side holes. To reach the target cell dose in
BM harvest, in March 2002 our institution adopted
the use of a multi–side-hole aspiration needle. We
restricted the amount of aspiration to 30 mL per punc-
ture, to reduce the effect of hemodilution. Our data
indicate that this new strategy led to an increased cell
density of BM products and, consequently, a higher
final cell dose for recipients.
In an effort to achieve even better results, in 2004,
we introduced midway TNC counts. This strategy
was designed to influence the practice of the collection
staff. Although we did not impose a strict rule to guide
the harvest based on themidwayTNC count, the strat-
egy significantly increased the cell density of the col-
lected BM. The final collected volume was higher in
group C compared with group B (995 mL vs 927 mL;
P\ .001). The increased harvest BM volume could
be one reason for the increased TNC count (189 
108 in group A, 201  108 in group B, and 245  108
in group C; P\ .001), but not for the increased BM
cell density (0. 202  108/mL, 0.219  108/mL, and
0.250  108/mL, respectively; P\ .001), because of
the negative correlation between collected BM volume
and cell density. The influence of the midway TNC
count might stem from the fact that staff were aware
of the unsatisfactory TNC counts and attempted to
improve harvest outcomes by further decreasing the
volume of aspiration per puncture to reduce hemodilu-
tion, using new puncture locations, and increasing the
final collected volume. The first two modifications
might play a major role in the increased final cell
density in group C by avoiding PB contamination.
Tanikawa et al. [14] first investigated the effect of
the multi–side-hole aspiration needle on BM harvest.
A higher mean TNC count was obtained with the
multi–side-hole needle compared with the single-hole
needle (33.06  103/mL vs 32.90  103/mL), but the
difference is not statistically significant in this small
study. Recently, Lannert et al. [15] demonstrated
that replacing the single-hole harvest needle with a
5–side-hole needle significantly shortened the BM
collection time, but had no effect on the cell density
of the harvested BM (0.22  108/mL for the single-
hole needle vs 0.18  108/mL for the multi–side-hole
needle; P 5 .427). The lack of difference between the
2 types of harvest needles in that study might result
from the effect of hemodilution by a large amount of
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puncture by themulti–side-hole needle). In the present
study, with the same multi–side-hole aspiration
needle but a smaller aspiration amount (30 mL per
puncture), we found a higher nucleated cell density
(0.219  108/mL for group B and 0.250  108/mL
for groupCwith themulti–side-hole needle) compared
with Lannert et al. [15]. This comparison suggests that
a small aspiration volume per puncture would improve
harvest outcome, which is consistent with the results of
previous studies using the single-hole needle [7,9].
Moreover, the small number of cases in the study of
Lannert et al. [15] might have caused that study to
have insufficient power to detect the difference.
As stated previously, the optimal final harvest vol-
ume should be balanced between the final cell yield
and the potential side effects on the donor. A surrogate
marker to predict final harvest outcome would be of
great help in determining the final target volume.
The midway TNC count during BM harvest can help
collection staff properly modify the harvest procedure
before it is completed. We found a highly significant
correlation between the midway and final cell densities
in groupC (r5 0.8774; P\ .001; Figure 2). These data
suggest that the midway cell density can be a good
predictor of the final cell density according to the
regression equation. Thus, the amount of aspiration
from each puncture and/or the target final BM volume
could be modified to obtain an adequate cell dose with
minimal iliac bone punctures. Indeed, this strategy sig-
nificantly decreased the incidence of an unacceptable
cell dose (\2 108/kg) from 3.6% to 0% in our study.
It is difficult to explainwhy thebaselineWBCcount
was slightly higher in groupC compared with the other
groups (5.97  103/mL in group A, 5.95  103/mL in
group B, and 6.25  103/mL in group C; P 5 .02).
The small difference in PB WBC counts might not
completely explain the increases in harvested cell den-
sity and cell dose. In multiple regression analysis, the
strategies of changing the harvest needle and perform-
ing midway TNC counts were significantly correlated
with the final cell density of the collected BM. Donor
weight, baseline WBC count, and harvest BM volume
remained independent factors affecting cell density,
similar to the conclusions of our previous study with
fewer cases [6].
Other studies have focused on methods of increas-
ing BM harvest yields. One study reported a reduction
in BM harvest time, but no increase in cell yield, from
raising the room temperature during BM collection
[8]. The working conditions for the collection staff
and the cost of heating limit the practicality of this
strategy, however. Several studies found increased
harvested cell yield and accelerated engraftment with
G-CSF–stimulated BM [10,11]; however, the use of
this method increases the cost of BM harvesting and
also raises the concern of additional side effects.In conclusion, this study demonstrates that use of
a multi–side-hole aspiration needle and a midway
TNC count are effective strategies for achieving
ahigher cell densityof harvestedBMand, consequently,
a higher cell dose for transplantation. We believe that
such strategies, accompanied by optimal donor selec-
tion will improve the outcome of BM transplantation.ACKNOWLEDGMENTS
Financial discolusre: The authors have no conflicts
of interest to disclose.REFERENCES
1. Sierra J, Storer B, Hansen JA, et al. Transplantation of marrow
cells from unrelated donors for treatment of high-risk acute leu-
kemia: the effect of leukemic burden, donorHLA-matching, and
marrow cell dose. Blood. 1997;89:4226-4235.
2. Barrett AJ, Ringden O, Zhang MJ, et al. Effect of nucleated
marrow cell dose on relapse and survival in identical twin bone
marrow transplants for leukemia. Blood. 2000;95:3323-3327.
3. Dominietto A, Lamparelli T, Raiola AM, et al. Transplant-
related mortality and long-term graft function are significantly
influenced by cell dose in patients undergoing allogeneic
marrow transplantation. Blood. 2002;100:3930-3934.
4. RochaV,LabopinM,GluckmanE, et al. Relevance of bonemar-
row cell dose on allogeneic transplantation outcomes for patients
with acute myeloid leukemia in first complete remission: results
of a European survey. J Clin Oncol. 2002;20:4324-4330.
5. Goldman JM. A special report. Bone marrow transplants using
volunteer donors: recommendations and requirements for
a standardized practice throughout the world, 1994 update.
The WMDA Executive Committee. Blood. 1994;84:2833-2839.
6. Kao RH, Li CC, ShawCK, et al. Correlation between character-
istics of unrelated bone marrow donor and cell density of total
nucleated cell in bone marrow harvest. Int J Hematol. 2009;89:
227-230.
7. Bacigalupo A, Tong J, PodestaM, et al. Bonemarrow harvest for
marrow transplantation: effect of multiple small (2 mL) or large
(20 mL) aspirates. Bone Marrow Transplant. 1992;9:467-470.
8. Zeller W, Hesse I, Durken M, et al. Increasing the yield of
harvested bone marrow cells by raising room temperature
during marrow collection. Exp Hematol. 1995;23:1527-1529.
9. Batinic D, Marusic M, Pavletic Z, et al. Relationship between
differing volumes of bone marrow aspirates and their cellular
composition. Bone Marrow Transplant. 1990;6:103-107.
10. Isola LM, Scigliano E, Skerrett D, et al. A pilot study of alloge-
neic bone marrow transplantation using related donors stimu-
lated with G-CSF. BoneMarrow Transplant. 1997;20:1033-1037.
11. Ji SQ, Chen HR, Wang HX, et al. Comparison of outcome of
allogeneic bone marrow transplantation with and without gran-
ulocyte colony-stimulating factor (lenograstim) donor-marrow
priming in patients with chronic myelogenous leukemia. Biol
Blood Marrow Transplant. 2002;8:261-267.
12. Stroncek DF, Holland PV, Bartch G, et al. Experiences of the
first 493 unrelated marrow donors in the National Marrow
Donor Program. Blood. 1993;81:1940-1946.
13. Confer DL, Miller JP. Optimal donor selection: beyond HLA.
Biol Blood Marrow Transplant. 2007;13:83-86.
14. Tanikawa S, Sakamaki H, Mori S, et al. Relationship between
the presence of side holes in bone marrow aspiration needle
and the number of harvested bone marrow mononuclear cells.
Rinsho Ketsueki. 1997;38:1249-1253.
15. Lannert H, Able T, Becker S, et al. Optimizing BM harvesting
from normal adult donors. Bone Marrow Transplant. 2008;42:
443-447.
